Novel quantitative digital image analysis methodology for assessment of inflammatory changes in MRI data in a post-hoc analysis of data acquired from a phase IIb study of baricitinib in patients with active rheumatoid arthritis.

Boesen, M; Beattie, S D; Schlichting, D E; Kubassova, O

Boesen, M; Beattie, S D; Schlichting, D E; Kubassova, O.

Afiliação

Boesen M; Department of Radiology, Copenhagen University Hospital Bispebjerg-Frederiksberg, Copenhagen, Denmark; Image Analysis Group, London, UK. Electronic address: mikael.ploug.boesen@regionh.dk.
Beattie SD; Eli Lilly and Company, Indianapolis, IN, USA.
Schlichting DE; Eli Lilly and Company, Indianapolis, IN, USA.
Kubassova O; Image Analysis Group, London, UK.

Eur J Radiol ; 143: 109877, 2021 Oct.

Article em En | MEDLINE | ID: mdl-34412009

Assuntos

Artrite Reumatoide; Azetidinas; Artrite Reumatoide/diagnóstico por imagem; Humanos; Imageamento por Ressonância Magnética; Purinas; Pirazóis; Sulfonamidas

Palavras-chave

Baricitinib; Biomarker; Inflammation; MRI; Quantitative imaging; Rheumatoid arthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Azetidinas Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google